NextPlat (NXPL) Short term Debt (2011 - 2020)

NextPlat's (NXPL) quarterly Short term Debt came in at $4798.0 in Q3 2020, down 61.42% quarter-over-quarter from $12435.0 in Q2 2020.

Analysis

NextPlat (NXPL) Short term Debt (2011 - 2020) Analysis & Trends

NextPlat (NXPL) has reported Short term Debt for 6 consecutive years, with $4798.0 the latest figure, recorded in Q3 2020.

On a quarterly basis, Short term Debt changed N/A year-over-year to $4798.0 in Q3 2020; TTM through Sep 2020 was $4798.0, a N/A change from a year earlier, with the FY2019 full-year figure at $24483.0, changed N/A from the prior year.
Short term Debt was $4798.0 for Q3 2020 at NextPlat, down from $12435.0 in the prior quarter.
Over five years, Short term Debt peaked at $24483.0 in Q4 2019 and troughed at $4798.0 in Q3 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	42.34 Bn	38.68 Bn	2.15 Bn
2	Viatris	19.39 Bn	18.50 Bn	1.46 Bn
3	Dr Reddys Laboratories	9.99 Bn	9.85 Bn	396.53 Mn
4	Amneal Pharmaceuticals	5.57 Bn	5.53 Bn	334.51 Mn
5	Bausch Health Companies	2.45 Bn	1.58 Bn	2.10 Bn
6	Ani Pharmaceuticals	1.70 Bn	1.34 Bn	165.89 Mn
7	Alvotech	1.66 Bn	1.52 Bn	2.56 Mn
8	Amphastar Pharmaceuticals	985.90 Mn	695.77 Mn	93.47 Mn
9	Fennec Pharmaceuticals	434.07 Mn	392.82 Mn	17.15 Mn
10	NextPlat	24.77 Mn	12.93 Mn	4.69 Mn

Historic Data

Download Data